A61K 39/099
Bordetella
Official title: {Bordetella}
A61K39/099 (Bordetella) appears on 232 US grants and 302 published applications in this corpus.
Search patents in A61K- Granted patents
- 232
- Published applications
- 302
- Assignees
- 186
- Inventors
- 593
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 3 |
| 2003 | 4 | 9 |
| 2004 | 4 | 8 |
| 2005 | 1 | 7 |
| 2006 | 2 | 7 |
| 2007 | 2 | 5 |
| 2008 | 3 | 9 |
| 2009 | 3 | 13 |
| 2010 | 2 | 19 |
| 2011 | 2 | 10 |
| 2012 | 2 | 7 |
| 2013 | 9 | 14 |
| 2014 | 12 | 20 |
| 2015 | 10 | 19 |
| 2016 | 18 | 16 |
| 2017 | 10 | 17 |
| 2018 | 16 | 11 |
| 2019 | 15 | 13 |
| 2020 | 9 | 16 |
| 2021 | 8 | 18 |
| 2022 | 12 | 13 |
| 2023 | 9 | 19 |
| 2024 | 9 | 12 |
| 2025 | 9 | 9 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lyophilized cake in straight-walled vial28 Jul 2026US 12,691,033 B2Elanco US Inc.
- Click outer membrane vesicles16 Jun 2026US 12,653,882 B2Intravacc B.V.
- Oral respiratory vaccine9 Jun 2026US 12,648,991 B2Intervet Inc.
- Transient expression of biologic materials17 Mar 2026US 12,576,041 B1
- Fermentation process24 Feb 2026US 12,559,713 B2Glaxosmithkline Biologicals SA
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Liquid Applicator for Delivering Vaccines23 Apr 2026US 2026/0108340 A1Boehringer Ingelheim Animal Health USA Inc.
- Optimized epicutaneous vaccination23 Apr 2026US 2026/0108593 A1Bionet-Asia, Co. Ltd.
- Diphtheria-tetanus-pertussis compound adjuvant combined vaccine16 Apr 2026US 2026/0102480 A1Changchun BCHT Biotechnology Co.
- Immunogenic proteins from bordetella pertussis26 Mar 2026US 2026/0083833 A1Ohio State Innovation Foundation
Most cited
By later US patents
- Avirulent microbes and uses therefor: Salmonella typhi109US 5,387,744 AWashington University · 1995
- Avirulent microbes and uses therefor: salmonella typhi103US 5,294,441 AWashington University · 1994
- Avirulent microbes and uses therefor102US 5,389,368 AWashington University · 1995
- Multiple vaccination including serogroup C meningococcus62US 8,444,992 B2Novartis Vaccines and Diagnostics, Inc. · 2013
- Transcutaneous delivery of therapeutic agents49US 8,728,491 B2Alba Therapeutics Corporation · 2014